# N4 Pharma encouraging data, oncology the quickest route to clinic (Interview)

- Link: https://www.directorstalkinterviews.com/n4-pharma-encouraging-data-oncology-the-quickest-route-to-clinic/4121047083
- Published: 2022-01-26T08:29:46+00:00
- Author: Giles

**N4 Pharma plc** (LON:N4P) CEO Nigel Theobald joins DirectorsTalk to discuss encouraging
data from its oncology research.

Nigel describes the behavior of Nuvec, explains why now a focus on oncology, work
on vaccines, funding and what investors can expect over the coming months.

N4 Pharma is a the specialist pharmaceutical company developing Nuvec®, a novel 
delivery system for cancer treatments and vaccines.

Share on:
